Company Filing History:
Years Active: 1999-2002
Title: Innovations of David Mark Brennand
Introduction
David Mark Brennand is a notable inventor based in Staple Grove, GB. He has made significant contributions to the field of biotechnology, particularly in the development of peptide analogues that have important applications in cell growth and chemotaxis.
Latest Patents
Brennand holds two patents related to platelet-derived growth factor analogues. These novel peptide analogues are designed for use in inhibiting or stimulating the growth and/or chemotaxis of cells, such as smooth muscle cells. The patents also include compositions of matter that comprise these peptide analogues, showcasing their potential in medical applications.
Career Highlights
Brennand is associated with Trigen GmbH, where he continues to innovate and develop new technologies. His work has been instrumental in advancing the understanding of cell behavior and growth factors.
Collaborations
Some of his notable coworkers include Geeta Patel and Yemisi Olabiran, who contribute to the collaborative efforts in research and development at Trigen GmbH.
Conclusion
David Mark Brennand's work in the field of peptide analogues represents a significant advancement in biotechnology. His patents and collaborations highlight his commitment to innovation and the potential impact of his inventions on medical science.